FMT in Initial CDI

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Clostridioides Difficile Infection

In brief

The study explores fecal microbiota transfer via retention enema after the first clostridioides difficile episode.

Key facts

Study ID

NCT05257538

Run by

Turku University Hospital

People needed

140

Starts

2021-08-01

Expected to finish

2028-02-28

Last updated by the study team

2025-04-11

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• >18 years
• C. difficile PCR in feces positive and clinical symptoms of enteritis.
• Full resolution of diarrhea during antibiotic treatment for C. difficile
• No other ongoing antibacterial treatments.
• No ongoing probiotics.
• Signed informed consent.

You may not qualify if…

• Pregnant
• Ongoing need for antibacterial treatment
• Life expectancy < 1 year
• Prior C. difficile infection in preceding 3 months
• Unable to provide written consent, due to dementia for example.
• Fecal incontinence i.e. inability to retain enema.

Where it is running

• Turku University hospital — Turku, Finland (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.